Literature DB >> 22609141

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.

Gordon H Guyatt1, Andrew D Oxman, Nancy Santesso, Mark Helfand, Gunn Vist, Regina Kunz, Jan Brozek, Susan Norris, Joerg Meerpohl, Ben Djulbegovic, Pablo Alonso-Coello, Piet N Post, Jason W Busse, Paul Glasziou, Robin Christensen, Holger J Schünemann.   

Abstract

Summary of Findings (SoF) tables present, for each of the seven (or fewer) most important outcomes, the following: the number of studies and number of participants; the confidence in effect estimates (quality of evidence); and the best estimates of relative and absolute effects. Potentially challenging choices in preparing SoF table include using direct evidence (which may have very few events) or indirect evidence (from a surrogate) as the best evidence for a treatment effect. If a surrogate is chosen, it must be labeled as substituting for the corresponding patient-important outcome. Another such choice is presenting evidence from low-quality randomized trials or high-quality observational studies. When in doubt, a reasonable approach is to present both sets of evidence; if the two bodies of evidence have similar quality but discrepant results, one would rate down further for inconsistency. For binary outcomes, relative risks (RRs) are the preferred measure of relative effect and, in most instances, are applied to the baseline or control group risks to generate absolute risks. Ideally, the baseline risks come from observational studies including representative patients and identifying easily measured prognostic factors that define groups at differing risk. In the absence of such studies, relevant randomized trials provide estimates of baseline risk. When confidence intervals (CIs) around the relative effect include no difference, one may simply state in the absolute risk column that results fail to show a difference, omit the point estimate and report only the CIs, or add a comment emphasizing the uncertainty associated with the point estimate.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22609141     DOI: 10.1016/j.jclinepi.2012.01.012

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  233 in total

Review 1.  Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.

Authors:  Tess E Cooper; Emma Fisher; Brian Anderson; Nick Mr Wilkinson; David G Williams; Christopher Eccleston
Journal:  Cochrane Database Syst Rev       Date:  2017-08-02

Review 2.  Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.

Authors:  Christopher Eccleston; Tess E Cooper; Emma Fisher; Brian Anderson; Nick Mr Wilkinson
Journal:  Cochrane Database Syst Rev       Date:  2017-08-02

Review 3.  Antidepressants for chronic non-cancer pain in children and adolescents.

Authors:  Tess E Cooper; Lauren C Heathcote; Jacqui Clinch; Jeffrey I Gold; Richard Howard; Susan M Lord; Neil Schechter; Chantal Wood; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-05

4.  The Practice Guidelines for Primary Care of Acute Abdomen 2015.

Authors:  Toshihiko Mayumi; Masahiro Yoshida; Susumu Tazuma; Akira Furukawa; Osamu Nishii; Kunihiro Shigematsu; Takeo Azuhata; Atsuo Itakura; Seiji Kamei; Hiroshi Kondo; Shigenobu Maeda; Hiroshi Mihara; Masafumi Mizooka; Toshihiko Nishidate; Hideaki Obara; Norio Sato; Yuichi Takayama; Tomoyuki Tsujikawa; Tomoyuki Fujii; Tetsuro Miyata; Izumi Maruyama; Hiroshi Honda; Koichi Hirata
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

Review 5.  Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials.

Authors:  Simon Tarp; Gil Amarilyo; Ivan Foeldvari; Robin Christensen; Jennifer M P Woo; Neta Cohen; Tracy D Pope; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2015-11-30       Impact factor: 7.580

Review 6.  Opioids for cancer-related pain in children and adolescents.

Authors:  Philip J Wiffen; Tess E Cooper; Anna-Karenia Anderson; Andrew L Gray; Marie-Claude Grégoire; Gustaf Ljungman; Boris Zernikow
Journal:  Cochrane Database Syst Rev       Date:  2017-07-19

Review 7.  Methadone for neuropathic pain in adults.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Roman Schumann
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

Review 8.  Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.

Authors:  Lars H Lundstrøm; Christophe Hv Duez; Anders K Nørskov; Charlotte V Rosenstock; Jakob L Thomsen; Ann Merete Møller; Søren Strande; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

Review 9.  Tramadol with or without paracetamol (acetaminophen) for cancer pain.

Authors:  Philip J Wiffen; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-05-16

10.  Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.

Authors:  Ariel Izcovich; Juan M Criniti; Federico Popoff; Liming Lu; Jiaming Wu; Walter Ageno; Daniel M Witt; Michael R Jaff; Sam Schulman; Veena Manja; Peter Verhamme; Gabriel Rada; Yuqing Zhang; Robby Nieuwlaat; Wojtek Wiercioch; Holger J Schünemann; Ignacio Neumann
Journal:  Blood Adv       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.